Torrent Pharma net profit rises 27 percent at Rs 310 crore in Q2
New Delhi: Drug firm Torrent Pharmaceuticals on Monday reported a 27.04 per cent rise in consolidated net profit to Rs 310 crore for the quarter ended September, mainly on account of robust sales in India and reduction in expenses.
The company had posted a net profit of Rs 244 crore for the corresponding period of the previous fiscal, Torrent Pharmaceuticals said in a filing to BSE.
Consolidated revenue from operations stood at Rs 2,017 crore for the quarter under consideration. It was Rs 2,005 crore for the same period a year ago.
India revenues grew to Rs 963 crore for the quarter ended September 30, 2020, as against Rs 899 crore earlier, Torrent Pharma said.
Read also: Biocon net profit declines 23 percent at Rs 195 crore in Q2
Total expenses dipped to Rs 1,639 crore as compared to Rs 1,743 crore in the second quarter of FY20.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.